China Pharma (NYSE:CPHI) Coverage Initiated at StockNews.com

StockNews.com initiated coverage on shares of China Pharma (NYSE:CPHIFree Report) in a research report report published on Tuesday. The firm issued a hold rating on the stock.

China Pharma Trading Up 10.6 %

Shares of CPHI opened at $0.21 on Tuesday. The company has a quick ratio of 0.26, a current ratio of 0.79 and a debt-to-equity ratio of 0.22. The company has a 50 day moving average price of $0.21 and a 200-day moving average price of $0.22. China Pharma has a fifty-two week low of $0.13 and a fifty-two week high of $0.69.

About China Pharma

(Get Free Report)

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.

Featured Articles

Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.